Evaluating Medication Optimization in Heart Failure: A Pharmacist’s Perspective

Keyphrases

• Heart Failure 100%
• Medicines Optimisation 100%
• Pharmacist Perspectives 100%
• Guideline-directed Medical Therapy 100%
• State Universities 60%
• Oklahoma 60%
• Optimal Dose 60%
• Heart Failure with Preserved Ejection Fraction (HFpEF) 60%
• University Medical Centre 60%
• Angiotensin Receptor Blockers 40%
• Beta-blockers 20%
• Patient Education 20%
• Titration 20%
• Therapy Initiation 20%
• Spironolactone 20%
• Heart Disease Diagnosis 20%
• Cardiology Clinic 20%
• Patients with Heart Failure 20%
• Retrospective Chart Review 20%
• Quality Improvement Initiatives 20%
• Echocardiogram 20%
• Pharmacist-managed 20%
• English Speaking 20%
• Medical Patients 20%
• Additional Needs 20%
• New-onset Heart Failure 20%
• Pharmacist-led Services 20%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 20%
• Inpatient Services 20%
• Emergency Department Services 20%
• Angiotensin Receptor-neprilysin Inhibitor 20%
• Therapeutic Education 20%
• Acute Exacerbation 20%
• Aldosterone Antagonists 20%
• Physician-led 20%
• Interdisciplinary Practice 20%

Medicine and Dentistry

• Combination Therapy 100%
• Drug Therapy 100%
• Congestive Heart Failure 100%
• Heart Failure with Reduced Ejection Fraction 60%
• Optimal Drug Dose 60%
• Angiotensin Receptor Antagonist 40%
• Cardiology 20%
• Emergency Department 20%
• Echocardiography 20%
• Quality Improvement 20%
• Spironolactone 20%
• Beta Adrenergic Receptor Blocking Agent 20%
• Enkephalinase Inhibitor 20%
• ACE Inhibitor 20%
• Aldosterone Antagonist 20%
• Titrimetry 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Combination Therapy 100%
• Congestive Heart Failure 100%
• Heart Failure with Reduced Ejection Fraction 60%
• Angiotensin Receptor Antagonist 40%
• Spironolactone 20%
• Beta Adrenergic Receptor Blocking Agent 20%
• Aldosterone Antagonist 20%
• Dipeptidyl Carboxypeptidase Inhibitor 20%
• Enkephalinase Inhibitor 20%